# Short-term high-intensity resistance training: a feasibility study on pulmonary, immune and physical-functional fitness benefits for older adults with metabolic syndrome

**Authors:** Juliana de Melo Batista dos Santos, Guilherme Eustáquio Furtado, Eviton Correa-Sousa, Maysa Alves Rodrigues Brandao-Rangel, Manoel Carneiro Oliveira-Junior, Katielle Rodrigues da Silva Cardoso, Mariana Alvarez de Souza, Francisco Rodrigues, Patricia Coelho, Luís Vicente Franco de Oliveira, André Luís Lacerda Bachi, Luciana Malosa Sampaio Jorge, Patrícia Sardinha Leonardo Lopes-Martins, Regiane Albertini, Rodolfo P. Vieira

PMC · DOI: 10.1007/s00421-025-05920-0 · European Journal of Applied Physiology · 2025-07-26

## TL;DR

This study shows that high-intensity resistance training can improve lung function, muscle strength, and immune health in older adults with metabolic syndrome.

## Contribution

The study demonstrates the feasibility and benefits of high-intensity resistance training for respiratory and immune health in older adults with metabolic syndrome.

## Key findings

- HIRT significantly improved lung mechanics and muscle strength in older adults with MetS.
- HIRT increased anti-inflammatory cytokines and reduced pro-inflammatory markers in both sputum and serum.
- HIRT led to a decrease in total leukocyte and other immune cell counts.

## Abstract

The incidence of metabolic syndrome (MetS) is rising rapidly, particularly among older adults, and is associated with comorbidities that impair respiratory and immune functions. Physical exercise has proven effective in mitigating the adverse effects of both aging and MetS. However, evidence on the impact of high-intensity resistance training (HIRT) on the respiratory and immune systems in older adults with MetS remains limited. This study aimed to evaluate the effects of HIRT on respiratory function, skeletal muscle strength, and immune modulation in older adults with MetS, highlighting its potential as a complementary therapeutic approach. A total of 43 older adults with MetS were enrolled and divided into two groups: a HIRT intervention group (n = 23; mean age 66.71 ± 4.98 years) and a non-exercising control group (n = 20; mean age 66.91 ± 5.26 years). The HIRT protocol involved twice-weekly sessions (10 total) over 5 weeks, performed at 80–90% of one-repetition maximum. Results showed that HIRT significantly improved lung mechanics (R5Hz, R20Hz, Z5Hz, X5Hz), peripheral muscle strength, and both maximal expiratory and inspiratory pressures. Furthermore, HIRT increased anti-inflammatory and anti-fibrotic cytokines in sputum (klotho, IL-10, adiponectin) and serum (klotho, relaxin-1, relaxin-3, IL-10), while reducing pro-inflammatory cytokines in sputum (IL-6, TNF-α) and serum (IL-1ra, IL-6, TNF-α, leptin). A decrease in total leukocyte, neutrophil, lymphocyte, and monocyte counts was also observed. In conclusion, HIRT effectively mitigates the effects of MetS on respiratory, muscular, and immune functions in older adults and may be recommended as a complementary strategy for managing MetS in this population.

The online version contains supplementary material available at 10.1007/s00421-025-05920-0.

## Linked entities

- **Proteins:** CG9701 (uncharacterized protein), IL10 (interleukin 10), RLN3 (relaxin 3), IL1R1 (interleukin 1 receptor type 1), IL6 (interleukin 6), TNF (tumor necrosis factor), lepa (leptin a)
- **Diseases:** metabolic syndrome (MONDO:0000816)

## Full-text entities

- **Genes:** IL1RN (interleukin 1 receptor antagonist) [NCBI Gene 3557] {aka CRMO2, DIRA, ICIL-1RA, IL-1RN, IL-1ra, IL-1ra3}, RLN1 (relaxin 1) [NCBI Gene 6013] {aka H1, H1RLX, RLXH1, bA12D24.3.1, bA12D24.3.2}, ADIPOQ (adiponectin, C1Q and collagen domain containing) [NCBI Gene 9370] {aka ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, KL (klotho) [NCBI Gene 9365] {aka HFTC3, KLA}, RLN3 (relaxin 3) [NCBI Gene 117579] {aka H3, RXN3, ZINS4, insl7}, LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}
- **Diseases:** MetS (MESH:D024821), inflammatory (MESH:D007249)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12881092/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12881092/full.md

---
Source: https://tomesphere.com/paper/PMC12881092